微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 16.56% | -22.33% | 1.47% | 118/131 | 51.25% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 16.32% | 12.57% | -5.51% | 122/131 | 52.33% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 17.27% | 16.33% | -18.06% | 118/131 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 21.08% | 37.17% | -1.14% | 116/131 | 53.5% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 21.32% | 1.56% | 47.07% | 112/131 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 14.5% | -37.3% | -2.36% | 120/131 | 53.31% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 14.85% | -42.96% | -3.38% | 116/131 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 15.37% | -46.44% | -26.81% | 120/131 | 53.45% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 20.99% | -32.09% | -9.21% | 110/131 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 23.12% | -45.94% | -11.17% | 116/131 | 53.83% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 26.03% | -42.63% | -9.28% | 107/131 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 28.69% | -34.97% | -7.2% | 110/131 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 30.92% | 2% | -27.72% | 98/131 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 42.77% | 35.35% | -5.73% | 98/131 | 57.29% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 45.37% | 2% | 2.84% | 80/131 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 44.12% | 58.23% | 39.62% | 90/131 | 58.42% | 正海生物 | 90.78% | 行业排名> |
| 2020-12-31 | 31.6% | 64.5% | 13.33% | 116/131 | 59.59% | 正海生物 | 91.59% | 行业排名> |
| 2020-06-30 | 27.88% | 2% | 45.15% | 103/131 | 59.94% | 正海生物 | 92.23% | 行业排名> |
| 2019-12-31 | 19.21% | -28.87% | -28.87% | 115/131 | 56.37% | 正海生物 | 92.69% | 行业排名> |
| 2018-12-31 | 27.01% | -12.15% | -12.15% | 102/131 | 55.53% | 正海生物 | 92.61% | 行业排名> |
| 2017-12-31 | 30.74% | 2% | 2% | 90/131 | 55.34% | 正海生物 | 94.38% | 行业排名> |